ROCKVILLE, Maryland, July 30 [Category: Health Care] -- The American Society of Addiction Medicine posted the following news release: * * * The ASAM Weekly for July 28, 2026 * ASAM Weekly -July 28 When Craving Predicts the Use of Methamphetamine: Lessons From the ADAPT-2 Trial By Manish K. Jha, MBBS; Udi Ghitza, PhD; and Madhukar H. Trivedi, MD Methamphetamine use disorder remains a significant public health issue with high rates of morbidity and mortality and the absence of any United States Food and Drug Administration (FDA)-approved more PR

LEVERKUSEN, Germany, July 30 [Category: BizPharmaceuticals] -- Bayer Group, a pharmaceutical and life sciences company, posted the following news release: * * * Bayer submits application for next indication of Kerendia in China * Berlin, July 30, 2026 - Bayer today announced the submission of a New Drug Application to the Center of Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA), seeking approval to extend the indication of finerenone in China to include adult patients with non-diabetic chronic kidney diseas more PR

KENT, Ohio, July 30 -- Kent State University posted the following news: * * * Four-Time Graduate Steps Into Ohio's State Superintendent Role * Philip Wagner's story begins in Northeast Ohio, but the arc of his career has always bent toward Kent State University. A first-generation and four-time college graduate, BA '88, MEd '90, Ed.S. '92, and Ph.D. '06, Wagner embodies the university's century-long commitment to preparing exceptional educators. Now, as he assumes the role of Ohio's State Superintendent of Public Instruction in August 2026, more PR

RARITAN, New Jersey, July 31 -- Johnson and Johnson Innovative Medicine issued the following news release on July 30, 2026: * * * Johnson & Johnson's RYBREVANT FASPRO(TM) (amivantamab and hyaluronidase-lpuj) receives U.S. FDA Priority Review as potential first-in-class EGFR- and MET-targeted subcutaneous treatment for advanced head and neck cancer Priority Review reinforces the significant potential of subcutaneous amivantamab in recurrent or metastatic head and neck cancer, where the current five-year survival rate is only 15 percent Patie more PR

DENVER, Colorado, July 29 [Category: Health Care] -- National Jewish Health, a respiratory hospital, issued the following news release: * * * National Jewish Health Appoints R. Stanton Dodge as Chair of Board of Directors * DENVER - R. Stanton Dodge has been named chair of the National Jewish Health Board of Directors. He has served as a member of the Board of Directors for 16 years. He succeeds Evan Zucker, who has served as board chair since July 2023 and will continue to serve as a member of the board and executive committee. Dodge ser more PR

THOUSAND OAKS, California, July 30 (TNSjou) -- SAGE Publishing issued the following news release: * * * Sage's 10-Year Impact Awards celebrate research with lasting influence Sage has awarded its seventh annual 10-Year Impact Awards, recognizing three academic papers that have demonstrated enduring influence over the decade since their publication. This year's awards honor the most-cited articles published in Sage journals in 2015. The 2026 winners are: * Loneliness and Social Isolation as Risk Factors for Mortality: A Meta-Analytic Revie more PR

DURHAM, North Carolina, July 31 -- The American Association of Independent Professional Baseball issued the following news release: * * * Schaub Extended, Garcia to Reds Org: Ten Things to Know in the American Association of Professional Baseball This Week Streaking Milkmen take East Lead, Overall Top Record, Lauded by Press as 'Fun for the Entire Family,' Highlighting Week for the MLB Partner League - A three-year extension of the contract of league Commissioner Joshua Schaub and the transfer of the Kansas City Monarchs' Ryan Garcia to t more PR

WASHINGTON, July 30 -- Sen. Roger Marshall, R-Kansas, issued the following news release: * * * Senator Marshall: Dr. Fauci's Lies Came Crumbling Down * Senator Marshall Joins Newsmax, The Record with Greta Van Susteren Washington - U.S. Senator Roger Marshall, M.D. (R-Kansas), joined The Record with Greta Van Susteren on Newsmax to discuss Dr. Fauci's hearing today, the latest evidence that he lied to the President and the American people, and how his deception hurt Americans and destroyed trust in government. Click HERE to download the f more PR